[ Prévalence de la Schistosiomiase à Schistosoma Haematobium chez les patients avec Hématurie: Cas de Centre de Santé de Référence Mabuilu de Nsioni, Territoire de Lukula, Province du Kongo Central en République Démocratique du Congo ]
Volume 38, Issue 1, November 2022, Pages 56–61
Nlandu Khonde Alphonse1
1 Institut Supérieur de Techniques Médicales de Tshela (ISTM, TSHELA), RD Congo
Original language: French
Copyright © 2022 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Schistosoma haematobium schistosomiasis or urogenital bilharziasis is a chronic parasitosis caused by Schistosoma haematobium. Worldwide, at least 206.5 million people needed treatment in 2016. Preventive treatment, which should be repeated over a number of years, will reduce and prevent morbidity. Transmission of schistosomiasis has been confirmed in 78 countries. However, preventive chemotherapy for schistosomiasis, where people and communities are targeted for large-scale treatment, is only needed in 52 moderately endemic to high transmission countries. In addition, 112 million people are infected with Schistosoma haematobium, including 80 million in its morbid form, causing 150,000 deaths per year. After our study and analysis, we found that out of a total of 50 samples, 8 were positive or 16% and 42 negative or 84%. Thus, the frequency of Schistosoma haematobium eggs was estimated at 16% during our study.
Author Keywords: prevalence, Schistosiomiasis, Heamatobium, patients, Hematuria.
Volume 38, Issue 1, November 2022, Pages 56–61
Nlandu Khonde Alphonse1
1 Institut Supérieur de Techniques Médicales de Tshela (ISTM, TSHELA), RD Congo
Original language: French
Copyright © 2022 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Schistosoma haematobium schistosomiasis or urogenital bilharziasis is a chronic parasitosis caused by Schistosoma haematobium. Worldwide, at least 206.5 million people needed treatment in 2016. Preventive treatment, which should be repeated over a number of years, will reduce and prevent morbidity. Transmission of schistosomiasis has been confirmed in 78 countries. However, preventive chemotherapy for schistosomiasis, where people and communities are targeted for large-scale treatment, is only needed in 52 moderately endemic to high transmission countries. In addition, 112 million people are infected with Schistosoma haematobium, including 80 million in its morbid form, causing 150,000 deaths per year. After our study and analysis, we found that out of a total of 50 samples, 8 were positive or 16% and 42 negative or 84%. Thus, the frequency of Schistosoma haematobium eggs was estimated at 16% during our study.
Author Keywords: prevalence, Schistosiomiasis, Heamatobium, patients, Hematuria.
Abstract: (french)
La schistosomiase à Schistosoma haematobium ou bilharziose uro-génitale est une parasitose chronique causée par le Schistosoma haematobium. Au monde, au moins 206,5 millions de personnes avaient besoin d’un traitement en 2016. Le traitement préventif, qui devrait se répéter sur certain nombre d’années, permettra de réduire et de prévenir la morbidité. La transmission de la schistosomiase est avérée dans 78 pays. Cependant, la chimiothérapie préventive pour la schistosomiase, où les gens et les communautés sont ciblés pour un traitement à grande échelle, est seulement nécessaire dans 52 pays d’endémie modérée à forte transmission. En plus, 112 millions de personnes seraient infectées par le Schistosoma haematobium dont 80 millions sous sa forme morbide, causant 150.000 décès par an. Après notre étude et analyse, nous avons constaté que sur un total de 50 échantillons, 8 étaient positif soit 16% et 42 négatifs soit 84%. Ainsi, la fréquence des œufs de Schistosoma haematobium était évaluée à 16% pendant notre étude.
Author Keywords: prévalence, Schistosiomiase, Heamatobium, patients, Hématurie.
How to Cite this Article
Nlandu Khonde Alphonse, “Prevalence of Schistosomiasis due to Schistosoma Haematobium in patients with Hematuria: Case from the Mabuilu Reference Health Center of Nsioni, Lukula Territory, Kongo Central Province in the Democratic Republic of Congo,” International Journal of Innovation and Applied Studies, vol. 38, no. 1, pp. 56–61, November 2022.
